Skip to main content

Articles

Page 55 of 70

  1. To compare the periodical incidence rates of genitourinary (GU) and gastrointestinal (GI) toxicity in patients who underwent prostate low-dose-rate brachytherapy between the monotherapy group (seed implantatio...

    Authors: Nobumichi Tanaka, Isao Asakawa, Satoshi Anai, Akihide Hirayama, Masatoshi Hasegawa, Noboru Konishi and Kiyohide Fujimoto
    Citation: Radiation Oncology 2013 8:25
  2. To describe post-CyberKnife® imaging characteristics of liver metastases as an aid in assessing response to treatment, and a novel set of combined criteria (CC) as an alternative to response according to chang...

    Authors: Hajer Jarraya, Xavier Mirabel, Sophie Taieb, Sylvain Dewas, Emmanuelle Tresch, Francois Bonodeau, Antoine Adenis, Andrew Kramar, Eric Lartigau and Luc Ceugnart
    Citation: Radiation Oncology 2013 8:24
  3. The ongoing EORTC 22042–26042 trial evaluates the efficacy of high-dose radiotherapy (RT) in atypical/malignant meningioma. The results of the Dummy Run (DR) and prospective Individual Case Review (ICR) were a...

    Authors: Mehtap Coskun, William Straube, Coen W Hurkmans, Christos Melidis, Patricia F de Haan, Salvador Villà, Sandra Collette and Damien C Weber
    Citation: Radiation Oncology 2013 8:23
  4. Purpose of this study is to explore the trade-offs between radio-induced toxicities and second malignant neoplasm (SMN) induction risk of different emerging radiotherapy techniques for Hodgkin’s lymphoma (HL) ...

    Authors: Laura Cella, Manuel Conson, Maria Cristina Pressello, Silvia Molinelli, Uwe Schneider, Vittorio Donato, Roberto Orecchia, Marco Salvatore and Roberto Pacelli
    Citation: Radiation Oncology 2013 8:22
  5. We performed this study to assess outcomes of patients with oropharyngeal cancer treated with modern therapy approaches.

    Authors: Adam S Garden, Merrill S Kies, William H Morrison, Randal S Weber, Steven J Frank, Bonnie S Glisson, Gary B Gunn, Beth M Beadle, K Kian Ang, David I Rosenthal and Erich M Sturgis
    Citation: Radiation Oncology 2013 8:21
  6. We report our experience in 49 consecutive patients with nasopharyngeal carcinoma who were treated by Intensity-modulated radiation therapy (IMRT) combined with simultaneous but not adjuvant chemotherapy (CHT).

    Authors: Ladan Saleh-Ebrahimi, Felix Zwicker, Marc W Muenter, Marc Bischof, Katja Lindel, Juergen Debus, Peter E Huber and Falk Roeder
    Citation: Radiation Oncology 2013 8:20
  7. Proton therapy can result in clinically significant radiation dermatitis. In some clinical scenarios, such as lung or breast cancer, the risk of severe radiation dermatitis may limit beam arrangement and presc...

    Authors: Jonathan T Whaley, Maura Kirk, Keith Cengel, James McDonough, Justin Bekelman and John P Christodouleas
    Citation: Radiation Oncology 2013 8:19
  8. Radiotherapy is controversially discussed in the management of benign disorders for fear of late sequelae such as tumor induction. This study was initiated to investigate long-term toxicity, treatment outcome ...

    Authors: Stefan Rieken, Daniel Habermehl, Thomas Welzel, Angela Mohr, Katja Lindel, Jürgen Debus and Stephanie E Combs
    Citation: Radiation Oncology 2013 8:18
  9. The radiation tolerance dose-volume in brain remains unclear for nasopharyngeal carcinoma (NPC) patients treated with intensity modulated radiotherapy (IMRT). We performed this study to investigate dosimetric ...

    Authors: Sheng-Fa Su, Shao-Ming Huang, Fei Han, Ying Huang, Chun-Yan Chen, Wei-Wei Xiao, Xue-Ming Sun and Tai-Xiang Lu
    Citation: Radiation Oncology 2013 8:17
  10. For cervical cancer patients treated with MR-guided high dose rate brachytherapy, the accuracy of radiation delivery depends on accurate localization of both tumors and the applicator, e.g. tandem and ovoid. S...

    Authors: Yanle Hu, Jacqueline Esthappan, Sasa Mutic, Susan Richardson, Hiram A Gay, Julie K Schwarz and Perry W Grigsby
    Citation: Radiation Oncology 2013 8:16
  11. Cranial reirradiation is clinically appropriate in some cases but cumulative radiation dose to critical normal structures remains a practical concern. The authors developed a simple technique in 3D conformal p...

    Authors: Mark W McDonald, Mark R Wolanski, Joseph W Simmons and Jeffrey C Buchsbaum
    Citation: Radiation Oncology 2013 8:14
  12. Radiation is a standard component of treatment for patients with locoregional recurrence (LRR) of breast cancer following mastectomy. The current study reports the results of a 10% radiation dose escalation in...

    Authors: Heath D Skinner, Eric A Strom, Sabin B Motwani, Wendy A Woodward, Marjorie C Green, Gildy Babiera, Daniel J Booser, Funda Meric-Bernstam and Thomas A Buchholz
    Citation: Radiation Oncology 2013 8:13
  13. To evaluate the survival of patients with human epidermal growth factor receptor 2 (HER2) positive and negative metastatic breast cancer irradiated for brain metastases before and after the availability of tra...

    Authors: Irene Karam, Sarah Hamilton, Alan Nichol, Ryan Woods, Caroline Speers, Hagen Kennecke and Scott Tyldesley
    Citation: Radiation Oncology 2013 8:12
  14. The purpose of this study was to identify parameters capable of predicting the deterioration of hepatic function after helical tomotherapy in patients with unresectable locally advanced hepatocellular carcinoma.

    Authors: Seok Hyun Son, Chul Seung Kay, Jin Ho Song, Sea-Won Lee, Byung Ock Choi, Young Nam Kang, Jeong Won Jang, Seung Kew Yoon and Hong Seok Jang
    Citation: Radiation Oncology 2013 8:11
  15. Based on the hypothesis that first-line chemoradiation followed by chemotherapy was superior for primary tumor and non-inferior for distant lesions compared to chemotherapy alone in synchronous unresectable di...

    Authors: Ji Zhu, Peng Lian, Fangqi Liu, Ye Xu, Junyan Xu, Zuqing Guan, Liping Liang, Minghe Wang, Sanjun Cai and Zhen Zhang
    Citation: Radiation Oncology 2013 8:10
  16. Intraoperative radiotherapy (IORT) is a new treatment approach for early stage breast cancer. This study reports on the effects of IORT on radiation-related quality of life (QoL) parameters.

    Authors: Grit Welzel, Angela Boch, Elena Sperk, Frank Hofmann, Uta Kraus-Tiefenbacher, Axel Gerhardt, Marc Suetterlin and Frederik Wenz
    Citation: Radiation Oncology 2013 8:9
  17. To determine the efficacy of high dose rate endobronchial brachytherapy (HDR-BT) for the treatment of centrally located lung tumors, two different fractionation schedules were compared regarding local tumor re...

    Authors: Olivier M Niemoeller, Barbara Pöllinger, Maximilian Niyazi, Stefanie Corradini, Farkhad Manapov, Claus Belka and Rudolf M Huber
    Citation: Radiation Oncology 2013 8:8
  18. Whole pelvis intensity modulated radiotherapy (IMRT) is increasingly being used to treat cervical cancer aiming to reduce side effects. Encouraged by this, some groups have proposed the use of simultaneous int...

    Authors: Fernanda G Herrera, Sharon Callaway, Ela Delikgoz-Soykut, Mehtap Coskun, Laetitia Porta, Jean-Yves Meuwly, Joao Soares-Rodrigues, Leonie Heym, Raphael Moeckli and Mahmut Ozsahin
    Citation: Radiation Oncology 2013 8:5
  19. Ongoing prospective trials exploring stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC) often exclude minimally invasive adenocarcinoma or adenocarcnioma in situ, former...

    Authors: Shahed N Badiyan, Andrew J Bierhals, Jeffrey R Olsen, Kimberly M Creach, Adam A Garsa, Todd DeWees, Jeffrey D Bradley and Clifford G Robinson
    Citation: Radiation Oncology 2013 8:4
  20. Currently, the inhomogeneity of the pulmonary function is not considered when treatment plans are generated in thoracic cancer radiotherapy. This study evaluates the dose of treatment plans on highly-functiona...

    Authors: Tzung-Chi Huang, Chien-Yi Hsiao, Chun-Ru Chien, Ji-An Liang, Tzu-Ching Shih and Geoffrey G Zhang
    Citation: Radiation Oncology 2013 8:3
  21. To evaluate the efficacy of radiotherapy (RT) for early-stage nodal and extranodal marginal zone lymphoma (MZL).

    Authors: Kristin Deinbeck, Hans Geinitz, Bernhard Haller and Khashayar Fakhrian
    Citation: Radiation Oncology 2013 8:2
  22. To integrate 3D MR spectroscopy imaging (MRSI) in the treatment planning system (TPS) for glioblastoma dose painting to guide simultaneous integrated boost (SIB) in intensity-modulated radiation therapy (IMRT).

    Authors: Soléakhéna Ken, Laure Vieillevigne, Xavier Franceries, Luc Simon, Caroline Supper, Jean-Albert Lotterie, Thomas Filleron, Vincent Lubrano, Isabelle Berry, Emmanuelle Cassol, Martine Delannes, Pierre Celsis, Elizabeth Moyal Cohen-Jonathan and Anne Laprie
    Citation: Radiation Oncology 2013 8:1
  23. For skull base meningiomas, several treatment paradigms are available: Observation with serial imaging, surgical resection, stereotactic radiosurgery, radiation therapy or some combination of both. The choice ...

    Authors: Stephanie E Combs, Ute Ganswindt, Robert L Foote, Douglas Kondziolka and Jörg-Christian Tonn
    Citation: Radiation Oncology 2012 7:226
  24. Skull base meningiomas commonly present with cranial neuropathies. Fractionated stereotactic radiation therapy (FSRT) has been used to treat these tumors with excellent local control, but rates of improvement ...

    Authors: Xinglei Shen, David W Andrews, Robert C Sergott, James J Evans, Walter J Curran, Mitchell Machtay, Ruben Fragoso, Harriet Eldredge, Colin E Champ, Matthew Witek, Mark V Mishra, Adam P Dicker and Maria Werner-Wasik
    Citation: Radiation Oncology 2012 7:225
  25. Hypothyroidism is a frequent late side effect of radiation therapy of the cervical region. Purpose of this work is to develop multivariate normal tissue complication probability (NTCP) models for radiation-ind...

    Authors: Laura Cella, Raffaele Liuzzi, Manuel Conson, Vittoria D’Avino, Marco Salvatore and Roberto Pacelli
    Citation: Radiation Oncology 2012 7:224
  26. As the incidence of cancer continues to rise, the use of radiotherapy has emerged as a leading treatment modality. Preclinical models in radiation oncology are essential tools for cancer research and therapeut...

    Authors: Jenna Kahn, Philip J Tofilon and Kevin Camphausen
    Citation: Radiation Oncology 2012 7:223
  27. The purpose of this study was to investigate whether the excision repair cross-complementation group 1 (ERCC1) mRNA expression could predict treatment response of patients with locally advanced cervical squamo...

    Authors: Zhou-lan Bai, Yan-yang Wang, Hong Zhe, Jian-li He and Ping Hai
    Citation: Radiation Oncology 2012 7:221
  28. Adjuvant radiation therapy (RT) with temozolomide (TMZ) is standard of care for high grade gliomas (HGG) patients. RT is commonly started 3 to 5 weeks after surgery. The deformation of the tumor bed and brain ...

    Authors: Colin E Champ, Joshua Siglin, Mark V Mishra, Xinglei Shen, Maria Werner-Wasik, David W Andrews, Sonal U Mayekar, Haisong Liu and Wenyin Shi
    Citation: Radiation Oncology 2012 7:220
  29. The utility of definitive radiotherapy (RT) for locoregionally advanced squamous cell carcinoma (SCC) of the larynx or hypopharynx in the setting of thyroid or cricoid cartilage invasion (TCCI) is controversia...

    Authors: Marcus M Wagner, Joel K Curé, Jimmy J Caudell, Sharon A Spencer, Lisle M Nabell, William R Carroll and James A Bonner
    Citation: Radiation Oncology 2012 7:219
  30. The use of stereotactic body radiotherapy (SBRT) is rapidly increasing. Presently, the most accurate method uses fiducial markers implanted near the tumor. A shortcoming of this method is that the beams turn o...

    Authors: Rie Yamazaki, Seiko Nishioka, Hiroyuki Date, Hiroki Shirato, Takao Koike and Takeshi Nishioka
    Citation: Radiation Oncology 2012 7:218
  31. Standard 3D-CRT after BCS may cause skin toxicity with a wide range of intensity including acute effects like erythema or late effects. In order to reduce these side effects it is mandatory to identify potenti...

    Authors: Uta Kraus-Tiefenbacher, Andreas Sfintizky, Grit Welzel, Anna Simeonova, Elena Sperk, Kerstin Siebenlist, Sabine Mai and Frederik Wenz
    Citation: Radiation Oncology 2012 7:217
  32. Studies suggest that patients with metastases limited in number and destination organ benefit from metastasis-directed therapy. Stereotactic body radiotherapy (SBRT) is commonly used for metastasis directed th...

    Authors: Abhishek A Solanki, Ralph R Weichselbaum, Daniel Appelbaum, Karl Farrey, Kamil M Yenice, Steven J Chmura and Joseph K Salama
    Citation: Radiation Oncology 2012 7:216
  33. The aim of this study was to compare the outcomes of postoperative adjuvant concomitant chemoradiotherapy using two different schedules of cisplatin for patients with high-risk oral squamous cell carcinoma (OS...

    Authors: Din-Li Tsan, Chien-Yu Lin, Chung-Jan Kang, Shiang-Fu Huang, Kang-Hsing Fan, Chun-Ta Liao, I-How Chen, Li-Yu Lee, Hung-Ming Wang and Joseph Tung Chieh Chang
    Citation: Radiation Oncology 2012 7:215
  34. Autophagy has attracted attentions as a novel mechanism for tumor development. In this study Human ovarian carcinoma cell line SKOV3 and multidrug-resistant phenotype SKVCR cells were used and the roles of aut...

    Authors: Bing Liang, Dejuan Kong, Yang Liu, Nan Liang, Mengzi He, Shumei Ma and Xiaodong Liu
    Citation: Radiation Oncology 2012 7:213
  35. This study investigates the use of TomoDirectTM 3DCRT for whole breast adjuvant radiotherapy (AWBRT) that represents a very attractive treatment opportunity, mainly for radiotherapy departments without convention...

    Authors: Valeria Casanova Borca, Pierfrancesco Franco, Paola Catuzzo, Fernanda Migliaccio, Flora Zenone, Stefania Aimonetto, Andrea Peruzzo, Massimo Pasquino, Giuliana Russo, Maria Rosa La Porta, Domenico Cante, Piera Sciacero, Giuseppe Girelli, Umberto Ricardi and Santi Tofani
    Citation: Radiation Oncology 2012 7:211
  36. The outcome of patients after radiotherapy (RT) for localized prostate cancer in case of prostate-specific antigen (PSA) progression during primary hormonal therapy (HT) is not well known.

    Authors: Michael Pinkawa, Marc D Piroth, Richard Holy, Victoria Djukic, Jens Klotz, David Pfister, Axel Heidenreich and Michael J Eble
    Citation: Radiation Oncology 2012 7:209
  37. To report early outcome and toxicity for inoperable patients with hepatocellular carcinoma (HCC) treated with volumetric modulated arc therapy (VMAT).

    Authors: Po-Ming Wang, Wei-Chung Hsu, Na-Na Chung, Feng-Ling Chang, Antonella Fogliata and Luca Cozzi
    Citation: Radiation Oncology 2012 7:207
  38. There is evidence that the extent of the G2/M arrest following irradiation is correlated with tumour cell survival and hence therapeutic success. We studied the regulation of cellular response to radiation tre...

    Authors: Nataša Anastasov, Ines Höfig, Iria Gonzalez Vasconcellos, Kristina Rappl, Herbert Braselmann, Natalie Ludyga, Gert Auer, Michaela Aubele and Michael J Atkinson
    Citation: Radiation Oncology 2012 7:206
  39. Breast tissue is among the most sensitive tissues to the carcinogenic actions of ionizing radiation and epidemiological studies have linked radiation exposure to breast cancer. Currently, molecular understandi...

    Authors: Kamal Datta, Daniel R Hyduke, Shubhankar Suman, Bo-Hyun Moon, Michael D Johnson and Albert J Fornace Jr
    Citation: Radiation Oncology 2012 7:205
  40. SBRT is a safe and efficient strategy to locally control multiple metastatic sites. While research in the physics domain for Flattening Filter Free Beams (FFF) beams is increasing, there are few clinical data ...

    Authors: Filippo Alongi, Antonella Fogliata, Elena Clerici, Pierina Navarria, Angelo Tozzi, Tiziana Comito, Anna Maria Ascolese, Alessandro Clivio, Francesca Lobefalo, Giacomo Reggiori, Luca Cozzi, Pietro Mancosu, Stefano Tomatis and Marta Scorsetti
    Citation: Radiation Oncology 2012 7:204
  41. The purpose of this study was to evaluate the technical feasibility of an image-guided intensity modulated radiotherapy (IG-IMRT) using involved-field technique to perform a hypofractionated schedule for patie...

    Authors: Seok Hyun Son, Jin Ho Song, Byung Ock Choi, Young nam Kang, Myung Ah Lee, Ki Mun Kang and Hong Seok Jang
    Citation: Radiation Oncology 2012 7:203
  42. Chemoradiation is the standard treatment for anal cancer. 3D conformal radiotherapy (3D-CRT) is usually split in 2 sequences with a therapeutic break (gap) in between. Intensity-modulated radiation therapy (IM...

    Authors: Claire Vautravers Dewas, Philippe Maingon, Cécile Dalban, Aurélie Petitfils, Karine Peignaux, Gilles Truc, Etienne Martin, Cédric Khoury, Sylvain Dewas and Gilles Créhange
    Citation: Radiation Oncology 2012 7:201

Annual Journal Metrics

  • 2022 Citation Impact
    3.6 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.370 - SNIP (Source Normalized Impact per Paper)
    1.037 - SJR (SCImago Journal Rank)

    2023 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    132 days submission to accept (Median)

    2023 Usage 
    1,958,690 downloads
    605 Altmetric mentions